John M. Kane, MD

Educational Activity

Metabolic Risks and Effects of Atypical Antipsychotic Treatment

October 15, 2007

Original Research

Can Antidepressants Be Used to Treat the Schizophrenia Prodrome? Results of a Prospective, Naturalistic Treatment Study of Adolescents

April 16, 2007

Academic Highlights

New Developments in the Treatment of Schizophrenia.

March 15, 2007

Original Research

Early Prediction of Antipsychotic Nonresponse Among Patients With Schizophrenia.

March 15, 2007

Original Research

Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine

February 15, 2007

ASCP Corner

Measurement-Based Psychiatry: Definitions of Response, Remission, Stability, and Relapse in Schizophrenia

November 15, 2006

ASCP Corner

Commentary on the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

May 15, 2006

Article

Review of Treatments That Can Ameliorate Nonadherence in Patients With Schizophrenia.

May 15, 2006

Original Research

Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs.

April 15, 2006

Original Research

Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials

January 16, 2006

Letter to the Editor

Reply to "Orally Distegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia"

November 15, 2005

Letter to the Editor

"Reply to Weight Gain and Antipsichotics."

July 15, 2005